| Feature | Standard Omega 5 (Punicic Acid) | PHGDG Omega 5 | |---------|--------------------------------|---------------| | Form | Free fatty acid or triglyceride | Glycerophospholipid (PG headgroup) | | Stability | Oxidizes within 4 weeks | Stabilized >12 months (via dihydrogen phosphate protection) | | Bioavailability | ~12% (enteric) | ~41% (lymphatic + direct cellular uptake) | | Target | Cytosolic PPARs | Mitochondrial inner membrane + PPARγ |
Critical Innovation: The dihydrogen phosphate group on the glycerol backbone prevents premature hydrolysis by pancreatic lipases, allowing the intact PHGDG molecule to enter enterocytes via CD36-mediated transport, not passive diffusion. Phdgd Omega 5
Given the potency of "Phdgd" grade oils, sourcing is critical. Because punicic acid is highly unsaturated, it is prone to rancidity (oxidation). A rancid Omega 5 oil is not only ineffective but inflammatory. | Feature | Standard Omega 5 (Punicic Acid)
Phdgd Omega 5 is generally recognized as safe (GRAS) by the FDA, but with caveats: Given the potency of "Phdgd" grade oils, sourcing
While fish oil lowers triglycerides, Phdgd Omega 5 targets a different set of markers. Human trials have shown that 800mg to 1g of punicic acid daily can:
| Molecule / Product | Claim | Advantage of PHGDG Omega 5 | |-------------------|-------|-----------------------------| | MitoQ (mitochondrial antioxidant) | Reduces ROS | PHGDG also remodels cardiolipin + induces mitophagy | | Urolithin A | Mitophagy activator | PHGDG has dual anti-inflammatory + metabolic effects | | Omega 3 phospholipids (e.g., Krill) | General CV health | Omega 5 conjugated triene is 10x more potent anti-inflammatory than EPA |
Patent status: WO/2024/015432 (Methods for treating age-related metabolic decline using phosphatidylglycerol-conjugated conjugated fatty acids) – priority US filing 2023, pending.